K. Okada et al., EFFECT OF FK-506 ADMINISTERED TONICALLY VERSUS INTRAMUSCULARLY ON SUPPRESSION OF THE CORNEAL IMMUNE-REACTION IN RATS, Ophthalmologica, 210(3), 1996, pp. 175-179
The immunosuppressive effect of FK 506 on penetrating keratoplasty in
rats was evaluated following intramuscular and topical administration,
Implanted corneal grafts were inspected weekly by clinical evaluation
for 3 weeks. Cytotoxic T lymphocyte (CTL) activity was measured in th
e spleen on postoperative day 21, and the grafts were examined histolo
gically. A dose of FK 506, 0.1 mg/kg given intramuscularly, only moder
ately suppressed CTL activity and the graft failed. In contrast, doses
of either 0.024 mg/day topically or 0.3 mg/kg intramuscularly suppres
sed CTL activity and the grafts remained intact. Results suggest that
FK 506 administered topically would be effective in preventing failure
of human corneal grafts.